Relative Potency and Selectivity of Calcium Antagonists Used in the Treatment of Migraine
- 1 March 1984
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 24 (2) , 55-58
- https://doi.org/10.1111/j.1526-4610.1984.hed2402055.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Nimodipine, a New Calcium Antagonist, in the Prophylactic Treatment of MigraineHeadache: The Journal of Head and Face Pain, 1983
- Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid HemorrhageNew England Journal of Medicine, 1983
- Flunarizine, a Calcium Channel Blocker: a New Prophylactic Drug in MigraineHeadache: The Journal of Head and Face Pain, 1983
- A Double‐blind Placebo‐controlled Prophylactic Study of Flunarizine (Sibelium®) in MigraineHeadache: The Journal of Head and Face Pain, 1981
- Sources of activator calcium in rabbit basilar arteryAmerican Journal of Physiology-Heart and Circulatory Physiology, 1981
- The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium-antagonistic dihydropyridines. An investigation of the mechanism of action of nimodipine.Circulation Research, 1981
- Nimodipine inhibits carbocyclic thromboxane-induced contractions of cerebral arteriesEuropean Journal of Pharmacology, 1981
- Evidence for greater susceptibility of isolated dog cerebral arteries to Ca antagonists than peripheral arteries.Stroke, 1980